Exclusive

Publication

Byline

Location

US Patent Issued on July 14 for "Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors" (British Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,841, issued on July 14. "Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors" was invented by Peter Hewitt (Craigavon, Great Britain), ... Read More


US Patent Issued to DANA-FARBER CANCER INSTITUTE on July 14 for "HCK as a therapeutic target in MYD88 mutated diseases" (American, Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,842, issued on July 14, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston). "HCK as a therapeutic target in MYD88 mutated diseases"... Read More


US Patent Issued to BioCryst Pharmaceuticals on July 14 for "Pyrrolopyrimidine amines as complement inhibitors" (Alabama Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,843, issued on July 14, was assigned to BioCryst Pharmaceuticals Inc. (Durham, N.C.). "Pyrrolopyrimidine amines as complement inhibitors" w... Read More


US Patent Issued to BeOne Medicines I on July 14 for "Imidazotriazine and pyrrolopyrimidine derivatives as KRAS G12C inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,844, issued on July 14, was assigned to BeOne Medicines I GmbH (Basel, Switzerland). "Imidazotriazine and pyrrolopyrimidine derivatives as ... Read More


US Patent Issued to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY on July 14 for "Crystal form of triazolopyridine-substituted indazole compound and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,845, issued on July 14, was assigned to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY Co. LTD. (Shenzhen, China). "Crystal form of triazolopyridin... Read More


US Patent Issued to KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY on July 14 for "Xanthone compound having excellent anticancer effect" (South Korean Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,846, issued on July 14, was assigned to KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (Busan, South Korea). "Xanthone compound having excel... Read More


US Patent Issued to Nalu Bio on July 14 for "Aryl-substituted n-alkyl indoles and their use as pharmacologically active agents" (American, Canadian Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,847, issued on July 14, was assigned to Nalu Bio Inc. (San Francisco). "Aryl-substituted n-alkyl indoles and their use as pharmacologically... Read More


US Patent Issued to Merck Sharp & Dohme on July 14 for "Plasma kallikrein inhibitors" (New Jersey, California, Connecticut Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,848, issued on July 14, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Plasma kallikrein inhibitors" was invented by Jianming Bao... Read More


US Patent Issued to LUPIN on July 14 for "Macrocyclic compounds as STING agonists" (Indian Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,849, issued on July 14, was assigned to LUPIN Ltd. (Maharashtra, India). "Macrocyclic compounds as STING agonists" was invented by Navnath ... Read More


US Patent Issued to Alumis on July 14 for "TYK2 inhibitors and uses thereof" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,850, issued on July 14, was assigned to Alumis Inc. (South San Francisco, Calif.). "TYK2 inhibitors and uses thereof" was invented by Bohan... Read More